{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:21:19Z","timestamp":1787570479254,"version":"build-2736575974"},"reference-count":180,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Funct. Biomater.","JFB"],"abstract":"<jats:p>Diabetes mellitus continues to impose a substantial global health burden, underscoring the need for therapeutic systems capable of achieving precise, adaptive, and patient-friendly glycemic control. Conventional diabetes treatments, including repeated insulin injections and oral hypoglycemic agents, are often constrained by non-physiological drug release, poor adherence, systemic side effects, and the persistent risk of hypoglycemia. In this context, glucose-responsive nanomedicine has emerged as a promising platform for next-generation diabetes therapy by enabling self-regulated and glucose-triggered delivery of insulin and other antidiabetic agents. This review highlights recent advances in glucose-responsive nanomedicine, focusing on the principal sensing mechanisms, including glucose oxidase-based, phenylboronic acid-based, and lectin-mediated systems, as well as the nanoscale carriers engineered to support them, such as polymeric nanoparticles, nanogels, micelles, liposomes, and hybrid nanostructures. These smart platforms offer significant potential to improve drug stability, enhance targeting efficiency, reduce dosing frequency, and more closely mimic endogenous insulin secretion. The review further examines their emerging role in precision diabetes care, particularly in combination with continuous glucose monitoring technologies, wearable devices, and closed-loop therapeutic systems. Despite notable progress at the preclinical level, important barriers to clinical translation remain, including challenges related to biocompatibility, long-term safety, reproducibility, scalable manufacturing, and regulatory approval. Collectively, glucose-responsive nanomedicine represents a rapidly advancing and clinically relevant field with the potential to redefine diabetes management through intelligent and personalized therapeutic strategies. This review provides a focused overview of current developments, key translational challenges, and future directions toward clinical implementation.<\/jats:p>","DOI":"10.3390\/jfb17090424","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:07:53Z","timestamp":1787566073000},"page":"424","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glucose-Responsive Nanomedicine in Diabetes Therapy: Emerging Advances and Clinical Prospects"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3698-2421","authenticated-orcid":false,"given":"Adnan","family":"Alsaei","sequence":"first","affiliation":[{"name":"Materials for Medicine Research Group, School of Medicine, Royal College of Surgeons in Ireland (RCSI), Medical University of Bahrain, Busaiteen 228, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4896-4210","authenticated-orcid":false,"given":"Ayah","family":"Binrajab","sequence":"additional","affiliation":[{"name":"Materials for Medicine Research Group, School of Medicine, Royal College of Surgeons in Ireland (RCSI), Medical University of Bahrain, Busaiteen 228, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahd","family":"Alsaei","sequence":"additional","affiliation":[{"name":"School of Population Health, RCSI University of Medicine and Health Sciences, 118 St Stephen\u2019s Green, Dublin 2, D02 YN77 Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0201-7791","authenticated-orcid":false,"given":"Fatema","family":"Rahimi","sequence":"additional","affiliation":[{"name":"Materials for Medicine Research Group, School of Medicine, Royal College of Surgeons in Ireland (RCSI), Medical University of Bahrain, Busaiteen 228, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0175-0425","authenticated-orcid":false,"given":"Ahmad","family":"Zarwi","sequence":"additional","affiliation":[{"name":"Materials for Medicine Research Group, School of Medicine, Royal College of Surgeons in Ireland (RCSI), Medical University of Bahrain, Busaiteen 228, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen N.","family":"Zarwi","sequence":"additional","affiliation":[{"name":"Materials for Medicine Research Group, School of Medicine, Royal College of Surgeons in Ireland (RCSI), Medical University of Bahrain, Busaiteen 228, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renad","family":"Alansari","sequence":"additional","affiliation":[{"name":"Materials for Medicine Research Group, School of Medicine, Royal College of Surgeons in Ireland (RCSI), Medical University of Bahrain, Busaiteen 228, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Roshan","family":"Deen","sequence":"additional","affiliation":[{"name":"Materials for Medicine Research Group, School of Medicine, Royal College of Surgeons in Ireland (RCSI), Medical University of Bahrain, Busaiteen 228, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Tegegne, B.A., Adugna, A., Yenet, A., Belay, W.Y., Yibeltal, Y., Dagne, A., Teffera, Z.H., Amare, G.A., Abebaw, D., and Tewabe, H. (2024). A critical review on diabetes mellitus type 1 and type 2 management approaches: From lifestyle modification to current and novel targets and therapeutic agents. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1440456"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Andreadi, A., Lodeserto, P., Todaro, F., Meloni, M., Romano, M., Minasi, A., Bellia, A., and Lauro, D. (2024). Nanomedicine in the treatment of diabetes. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25137028"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1007\/s00125-021-05568-3","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"64","author":"Holt","year":"2021","journal-title":"Diabetologia"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2024). 2. Diagnosis and classification of diabetes: Standards of care in diabetes-2024. Diabetes Care, 47, S20\u2013S42.","DOI":"10.2337\/dc24-S002"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s12325-025-03185-9","article-title":"Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments","volume":"42","author":"Islam","year":"2025","journal-title":"Adv. Ther."},{"key":"ref_6","unstructured":"World Health Organization (2026, May 15). Diabetes [Internet]. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes."},{"key":"ref_7","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2024). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: A pooled analysis of 1108 population-representative studies with 141 million participants. Lancet, 404, 2077\u20132093."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S2213-8587(25)00217-7","article-title":"Global, regional, and national cascades of diabetes care, 2000\u20132023: A systematic review and modelling analysis using findings from the Global Burden of Disease Study","volume":"13","author":"Stafford","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23779608231185921","DOI":"10.1177\/23779608231185921","article-title":"Predicting factors of health-related quality of life among adults with type 2 diabetes: A systematic review","volume":"9","author":"Teli","year":"2023","journal-title":"SAGE Open Nurs."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Oluchi, S.E., Manaf, R.A., Ismail, S., Shahar, H.K., Mahmud, A., and Udeani, T.K. (2021). Health related quality of life measurements for di-abetes: A systematic review. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18179245"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5164503","DOI":"10.1155\/jdr\/5164503","article-title":"Health-related quality of life and psychosocial outcomes in patients with type 2 diabetes mellitus: A bibliometric analysis","volume":"2025","author":"Liu","year":"2025","journal-title":"J. Diabetes Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kaushal, A., Musafir, A., Sharma, G., Rani, S., Singh, R.K., Kumar, A., Bhadada, S.K., Barnwal, R.P., and Singh, G. (2025). Revolutionizing Diabetes Management Through Nanotechnology-Driven Smart Systems. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17060777"},{"key":"ref_13","first-page":"322","article-title":"Update on the Status of Glucose-Responsive Insulins","volume":"43","author":"Brouillard","year":"2025","journal-title":"Clin. Diabetes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e13558","DOI":"10.1111\/1753-0407.13558","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes","volume":"16","author":"Gong","year":"2024","journal-title":"J. Diabetes"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2296350","DOI":"10.1080\/10717544.2023.2296350","article-title":"Biodegradable polymeric insulin microneedles\u2014A design and materials perspective review","volume":"31","author":"Chellathurai","year":"2024","journal-title":"Drug Deliv."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.dsx.2018.10.008","article-title":"Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention","volume":"13","author":"Tan","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"16645","DOI":"10.1039\/D5SC02817E","article-title":"Fully dissolved glucose-responsive insulin delivery system based on a self-immolative insulin prodrug and glucose oxidase","volume":"16","author":"Kitaoka","year":"2025","journal-title":"Chem. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e2403594","DOI":"10.1002\/adma.202403594","article-title":"A Glucose-Responsive Cannula for Automated and Electronics-Free Insulin Delivery","volume":"36","author":"Fuchs","year":"2024","journal-title":"Adv. Mater."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"115194","DOI":"10.1016\/j.addr.2024.115194","article-title":"Emerging strategies for nanomedicine in autoimmunity","volume":"207","author":"Thatte","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Alsaei, A., Zarwi, A., Binrajab, A., Rahimi, F., AlAnsari, R., Kumar, M.P., Butler, A.E., Atkin, S.L., and Deen, G.R. (2026). Alginate-based biomaterials: From fundamental \u201cEgg-Box\u201d chemistry to diverse biomedical and metabolic management of obesity and diabetes. Gels, 12.","DOI":"10.3390\/gels12030250"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tem.2020.02.001","article-title":"Nanomedicine-based strategies for diabetes: Diagnostics, monitoring, and treatment","volume":"31","author":"Lemmerman","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_22","first-page":"62","article-title":"Trends of nanotechnology in type 2 diabetes mellitus treatment","volume":"16","author":"Simos","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.addr.2020.09.013","article-title":"Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapies","volume":"170","author":"Nelson","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11427-017-9257-1","article-title":"Nanomedicine for obesity treatment","volume":"61","author":"Zhang","year":"2018","journal-title":"Sci. China Life Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"109966","DOI":"10.1016\/j.diabres.2022.109966","article-title":"Application progress of nanotechnology in regenerative medicine of diabetes mellitus","volume":"190","author":"Li","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_26","first-page":"392","article-title":"Advances in oral peptide drug nanoparticles for diabetes mellitus treatment","volume":"15","author":"Li","year":"2022","journal-title":"Bioact. Mater."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Guan, W., and Zhang, L. (2025). Applications and prospects of biomaterials in diabetes management. Front Bioeng. Biotechnol., 13.","DOI":"10.3389\/fbioe.2025.1547343"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.25122\/jml-2023-0355","article-title":"Efficacy of oral insulin nanoparticles for the management of hyperglycemia in a rat model of diabetes induced with streptozotocin","volume":"17","author":"Alatrakji","year":"2024","journal-title":"J. Med. Life."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Liu, J., Ren, Z.H., Qiang, H., Wu, J., Shen, M., Zhang, L., and Lyu, J. (2020). Trends in the incidence of diabetes mellitus: Results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-09502-x"},{"key":"ref_31","unstructured":"GBD 2021 Diabetes Collaborators (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet, 402, 203\u2013234."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","article-title":"The burden and risks of emerging complications of diabetes mellitus","volume":"18","author":"Tomic","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00125-021-05398-3","article-title":"Current and future therapies for type 1 diabetes","volume":"64","author":"Kreiner","year":"2021","journal-title":"Diabetologia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Garcia-Saenz, M., Gomez-Romero, O.J., Espinosa-Cardenas, E., Ramirez-Renteria, C., Doval-Caballero, J.L.E., Uribe-Cortes, D., and Ferreira-Hermosillo, A. (2026). Advances in insulin delivery: Transdermal and needle-free technologies as emerging strategies to improve metabolic control and treatment adherence. Life, 16.","DOI":"10.3390\/life16030377"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s13300-016-0187-6","article-title":"Lipodystrophy in insulin-treated subjects and other injection-site skin reactions: Are we sure everything is clear?","volume":"7","author":"Gentile","year":"2016","journal-title":"Diabetes Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.3390\/ph3093005","article-title":"Oral hypoglycemic drugs: Pathophysiological basis of their mechanism of action","volume":"3","author":"Lorenzati","year":"2010","journal-title":"Pharmaceuticals"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3390\/jcm3030923","article-title":"Importance of beta cell function for the treatment of type 2 diabetes","volume":"3","author":"Saisho","year":"2014","journal-title":"J. Clin. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Froldi, G. (2024). View on metformin: Antidiabetic and pleiotropic effects, pharmacokinetics, side effects, and sex-related differences. Pharmaceuticals, 17.","DOI":"10.3390\/ph17040478"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11892-019-1270-y","article-title":"Thiazolidinediones: The forgotten diabetes medications","volume":"19","author":"Lebovitz","year":"2019","journal-title":"Curr. Diab Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2042098621989134","DOI":"10.1177\/2042098621989134","article-title":"Adverse events associated with sodium-glucose co-transporter 2 inhibitors: An overview of quantitative systematic reviews","volume":"12","author":"Pelletier","year":"2021","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00125-018-4548-8","article-title":"Impaired hypoglycaemia awareness in type 1 diabetes: Lessons from the lab","volume":"61","author":"McNeilly","year":"2018","journal-title":"Diabetologia"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ecl.2010.05.003","article-title":"Hypoglycemia in type 1 diabetes mellitus","volume":"39","author":"Cryer","year":"2010","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/diaspect.28.1.32","article-title":"Exercise strategies for hypoglycemia prevention in individuals with type 1 diabetes","volume":"28","author":"Yardley","year":"2015","journal-title":"Diabetes Spectr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/nyas.14214","article-title":"Hypoglycemia-associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 dia-betes","volume":"1454","author":"Rickels","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/1559827617722137","article-title":"Alcohol use in young adults with type 1 diabetes mellitus","volume":"11","author":"White","year":"2017","journal-title":"Am. J. Lifestyle Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5114\/aoms.2015.53304","article-title":"Sulfonylureas and their use in clinical practice","volume":"11","author":"Sola","year":"2015","journal-title":"Arch. Med. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pds.4337","article-title":"Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study","volume":"27","author":"Leonard","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.4239\/wjd.v12.i12.2036","article-title":"Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention","volume":"12","author":"Nakhleh","year":"2021","journal-title":"World J. Diabetes"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13098-022-00785-1","article-title":"Adherence and persistence rates of major antidiabetic medications: A review","volume":"14","author":"Lee","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.2147\/DDDT.S79322","article-title":"Insulin administration: Present strategies and future directions for a noninvasive (possibly more physiological) delivery","volume":"9","author":"Matteucci","year":"2015","journal-title":"Drug Des. Devel Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2230-973X.176456","article-title":"Insulin delivery methods: Past, present and future","volume":"6","author":"Shah","year":"2016","journal-title":"Int. J. Pharm. Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1177\/193229681100500635","article-title":"Actionable self-monitoring of blood glucose: Redefining the role for patients using multiple daily injection therapy","volume":"5","author":"Kerr","year":"2011","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Rahman, N.A., Lim, M.T., Thevendran, S., Hamdi, N.A., and Sivasampu, S. (2022). Medication regimen complexity and medication burden among patients with type 2 diabetes mellitus: A retrospective analysis. Front Pharmacol., 13.","DOI":"10.3389\/fphar.2022.808190"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s13300-024-01559-w","article-title":"Adherence and persistence to basal insulin among people with type 2 diabetes in Europe: A systematic literature review and meta-analysis","volume":"15","author":"Gimeno","year":"2024","journal-title":"Diabetes Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/dom.14603","article-title":"Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic liter-ature review","volume":"24","author":"Evans","year":"2022","journal-title":"Diabetes Obes. Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2337\/dc09-1348","article-title":"Correlates of insulin injection omission","volume":"33","author":"Peyrot","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tibtech.2019.12.021","article-title":"Enabling technologies for personalized and precision medicine","volume":"38","author":"Ho","year":"2020","journal-title":"Trends Biotechnol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00125-021-05391-w","article-title":"New closed-loop insulin systems","volume":"64","author":"Boughton","year":"2021","journal-title":"Diabetologia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tips.2020.11.002","article-title":"Developing insulin delivery devices with glucose responsiveness","volume":"42","author":"Wang","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2469490","DOI":"10.1080\/14686996.2025.2469490","article-title":"Advances in bioinspired polymer hydrogel systems with biomedical functionalities","volume":"26","author":"Ishihara","year":"2025","journal-title":"Sci. Technol. Adv. Mater."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2008.08.009","article-title":"Chemically controlled closed-loop insulin delivery","volume":"132","author":"Ravaine","year":"2008","journal-title":"J. Control Release"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2020.02.014","article-title":"Recent progress in design and preparation of glu-cose-responsive insulin delivery systems","volume":"321","author":"Shen","year":"2020","journal-title":"J. Control Release"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Caturano, A., Nilo, R., Nilo, D., Russo, V., Santonastaso, E., Galiero, R., Rinaldi, L., Monda, M., Sardu, C., and Marfella, R. (2024). Advances in nanomedicine for precision insulin delivery. Pharmaceuticals, 17.","DOI":"10.3390\/ph17070945"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"rbac056","DOI":"10.1093\/rb\/rbac056","article-title":"Recent advances in glucose-responsive insulin delivery systems: Novel hydrogels and future applications","volume":"9","author":"Mohanty","year":"2022","journal-title":"Regen. Biomater."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3109\/1061186X.2015.1055749","article-title":"Smart approaches to glucose-responsive drug delivery","volume":"23","author":"Webber","year":"2015","journal-title":"J. Drug Target."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s41565-024-01764-5","article-title":"An orally administered glucose-responsive polymeric complex for high-efficiency and safe delivery of insulin in mice and pigs","volume":"19","author":"Ji","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Kim, K.O. (2026). PH and glucose dual-responsive hybrid polymeric smart insulin carrier for diabetes treatment. Polymers, 18.","DOI":"10.3390\/polym18101209"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MED.0000000000000345","article-title":"Development of glucose-responsive \u2018smart\u2019 insulin systems","volume":"24","author":"Rege","year":"2017","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.2147\/IJN.S508875","article-title":"Nano-based drug delivery systems for managing diabetes: Recent advances and future prospects","volume":"20","author":"Liu","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2020.01.038","article-title":"PH-sensitive MOF integrated with glucose oxidase for glucose-responsive insulin delivery","volume":"320","author":"Zhang","year":"2020","journal-title":"J. Control Release"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1039\/D5PM00083A","article-title":"Phenylboronic acid derivatives: Advancing glucose-responsive insulin delivery and multifunctional biomedical applications","volume":"2","author":"Roy","year":"2025","journal-title":"RSC Pharm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"115805","DOI":"10.1016\/j.matdes.2026.115805","article-title":"Smart nanomaterial-based therapeutics for the management of diabetes and its complications","volume":"264","author":"Lakharwal","year":"2026","journal-title":"Mater. Des."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Offler, L.J., Wells, L.K., and Palmer, T.M. (2025). The impact of glycaemic variability on vascular dysfunction in diabetes. Biomolecules, 15.","DOI":"10.3390\/biom15111544"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrd4477","article-title":"Managing diabetes with nanomedicine: Challenges and oppor-tunities","volume":"14","author":"Veiseh","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2017.09.003","article-title":"Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment","volume":"264","author":"Wong","year":"2017","journal-title":"J. Control Release"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Marques, L., Costa, B., Pereira, M., Silva, A., Santos, J., Saldanha, L., Silva, I., Magalh\u00e3es, P., Schmidt, S., and Vale, N. (2024). Advancing precision medicine: A review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16030332"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1177\/193229680900300439","article-title":"Exercise and glucose metabolism in persons with diabetes mellitus: Perspectives on the role for con-tinuous glucose monitoring","volume":"3","author":"Riddell","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1021\/nn400630x","article-title":"Injectable nano-network for glucose-mediated insulin delivery","volume":"7","author":"Gu","year":"2013","journal-title":"ACS Nano"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s11671-025-04215-9","article-title":"Systematic review of peptide nanoparticles for improved diabetes outcomes: Insights and opportunities","volume":"20","author":"Dangana","year":"2025","journal-title":"Discov. Nano."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41378-025-01089-w","article-title":"Integrated individually addressable microneedle arrays for robust glucose monitoring and on-demand insulin releasing","volume":"11","author":"Wei","year":"2025","journal-title":"Microsyst. Nanoeng."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/acsmaterialsau.4c00138","article-title":"Glucose-Responsive Materials for Smart Insulin Delivery: From Protein-Based to Protein-Free Design","volume":"5","author":"Pal","year":"2025","journal-title":"ACS Mater. Au."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Li, L., and Wang, Y. (2025). Advancements in Injectable Hydrogels for Controlled Insulin Delivery: A Comprehensive Review of the Design, Properties and Therapeutic Applications for Diabetes and Its Complications. Polymers, 17.","DOI":"10.3390\/polym17060780"},{"key":"ref_84","first-page":"16","article-title":"Advances in injectable and transdermal glucose-responsive insulin delivery systems","volume":"55","author":"Li","year":"2026","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1021\/accountsmr.2c00094","article-title":"Materials and carriers development for glucose-responsive insulin","volume":"3","author":"Yao","year":"2022","journal-title":"Acc. Mater. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/acsnano.9b06395","article-title":"Glucose-responsive nanoparticles for rapid and extended self-regulated insulin delivery","volume":"14","author":"Volpatti","year":"2020","journal-title":"ACS Nano"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/acsnano.6b06892","article-title":"H2O2-responsive vesicles integrated with transcutaneous patches for glucose-mediated insulin delivery","volume":"11","author":"Hu","year":"2017","journal-title":"ACS Nano"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.7150\/thno.98177","article-title":"PH and H2O2 dual-sensitive nanoparticles enable enhanced and safe glucose-responsive oral insulin delivery for diabetes mellitus treatment","volume":"14","author":"Li","year":"2024","journal-title":"Theranostics"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1021\/bm500364a","article-title":"Bio-inspired synthetic nanovesicles for glucose-responsive release of insulin","volume":"15","author":"Tai","year":"2014","journal-title":"Biomacromolecules"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Zhao, L., Wang, L., Zhang, Y., Xiao, S., Bi, F., Zhao, J., Gai, G., and Ding, J. (2017). Glucose oxidase-based glucose-sensitive drug delivery for diabetes treatment. Polymers, 9.","DOI":"10.3390\/polym9070255"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Morariu, S. (2023). Advances in the Design of Phenylboronic acid-based glucose-sensitive hydrogels. Polymers, 15.","DOI":"10.3390\/polym15030582"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/IJN.S284357","article-title":"Bioresponsive functional phenylboronic acid-based delivery system as an emerging platform for diabetic therapy","volume":"16","author":"Ma","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Wang, C., Lin, B., Zhu, H., Bi, F., Xiao, S., Wang, L., Gai, G., and Zhao, L. (2019). Recent Advances in Phenylboronic Acid-Based Gels with Potential for Self-Regulated Drug Delivery. Molecules, 24.","DOI":"10.3390\/molecules24061089"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"21894","DOI":"10.1038\/s41598-021-01216-3","article-title":"Insulin smart drug delivery nanoparticles of aminophenylboronic acid-POSS molecule at neutral pH","volume":"11","author":"Kim","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Sarkhel, S., Shuvo, S.M., Ansari, M.A., Mondal, S., Kapat, P., Ghosh, A., Sarkar, T., Biswas, R., Atanase, L.I., and Carauleanu, A. (2024). Nanotechnology-Based Approaches for the Management of Diabetes Mellitus: An Innovative Solution to Long-Lasting Challenges in Antidiabetic Drug Delivery. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16121572"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bios.2014.03.040","article-title":"Concanavalin A-polysaccharides binding affinity analysis using a quartz crystal microbalance","volume":"59","author":"Coulibaly","year":"2014","journal-title":"Biosens. Bioelectron."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1529\/biophysj.108.134601","article-title":"The role of metal ions in substrate recognition and stability of concanavalin A: A molecular dynamics study","volume":"96","author":"Kaushik","year":"2009","journal-title":"Biophys. J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"9091","DOI":"10.1021\/ac501791u","article-title":"PEGylation of concanavalin A to improve its stability for an in vivo glucose sensing assay","volume":"86","author":"Locke","year":"2014","journal-title":"Anal. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1932296819854105","article-title":"Glucose-Responsive Insulin Through Bioconjugation Approaches","volume":"14","author":"Disotuar","year":"2020","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Bercea, M., and Lupu, A. (2024). Recent Insights into Glucose-Responsive Concanavalin A-Based Smart Hydrogels for Controlled Insulin Delivery. Gels, 10.","DOI":"10.3390\/gels10040260"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Mansoor, S., Adeyemi, S.A., Kondiah, P.P.D., and Choonara, Y.E. (2023). A closed loop stimuli-responsive concanavalin A-loaded chitosan\u2013pluronic hydrogel for glucose-responsive delivery of short-acting insulin prototyped in RIN-5F pancreatic cells. Biomedicines, 11.","DOI":"10.3390\/biomedicines11092545"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"8260","DOI":"10.1073\/pnas.1505405112","article-title":"Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery","volume":"112","author":"Yu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1021\/acs.nanolett.6b03848","article-title":"Hypoxia and H2O2 Dual-Sensitive Vesicles for Enhanced Glu-cose-Responsive Insulin Delivery","volume":"17","author":"Yu","year":"2017","journal-title":"Nano Lett."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1021\/acs.biomac.2c00016","article-title":"Glucose and H2O2 Dual-responsive nanocomplex grafted with insulin prodrug for blood glucose regulation","volume":"23","author":"Xu","year":"2022","journal-title":"Biomacromolecules"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1021\/acs.biomac.1c00772","article-title":"Glucose and pH Dual-Responsive Polymersomes with Multilevel Self-Regulation of Blood Glucose for Insulin Delivery","volume":"22","author":"Zhou","year":"2021","journal-title":"Biomacromolecules"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ijpharm.2018.07.020","article-title":"A stimuli-responsive insulin delivery system based on reversible phenyl-boronate modified cyclodextrin with glucose triggered host-guest interaction","volume":"548","author":"Xu","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"22654","DOI":"10.1038\/srep22654","article-title":"Simultaneous expression and transportation of insulin by supramolecular polysac-charide nanocluster","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Dong, Z., Kang, Y., Yuan, Q., Luo, M., and Gu, Z. (2018). H2O2-responsive nanoparticle based on the supramolecular self-assemble of cy-clodextrin. Front Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00552"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"33202","DOI":"10.1021\/acsomega.3c03746","article-title":"Cyclodextrin Host-Guest Recognition in Glucose-Monitoring Sensors","volume":"8","author":"Javanbakht","year":"2023","journal-title":"ACS Omega"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1073\/pnas.1424684112","article-title":"Glucose-responsive insulin activity by covalent modifi-cation with aliphatic phenylboronic acid conjugates","volume":"112","author":"Chou","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"101107","DOI":"10.1016\/j.molmet.2020.101107","article-title":"Review: Glucose-sensitive insulin","volume":"46","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cpt.1215","article-title":"Clinical Evaluation of MK-2640: An Insulin Analog With Glucose-Responsive Properties","volume":"105","author":"Krug","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Zieli\u0144ska, A., Carreir\u00f3, F., Oliveira, A.M., Neves, A., Pires, B., Venkatesh, D.N., Durazzo, A., Lucarini, M., Eder, P., and Silva, A.M. (2020). Polymeric Nanoparticles: Production, Charac-terization, Toxicology and Ecotoxicology. Molecules, 25.","DOI":"10.3390\/molecules25163731"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Shakya, A.K., Al-Sulaibi, M., Naik, R.R., Nsairat, H., Suboh, S., and Abulaila, A. (2023). Review on PLGA Polymer Based Nanoparticles with Antimicrobial Properties and Their Application in Various Medical Conditions or Infections. Polymers, 15.","DOI":"10.3390\/polym15173597"},{"key":"ref_115","first-page":"1035","article-title":"Effects of insulin-loaded chitosan-alginate nanoparticles on RAGE expression and oxidative stress status in the kidney tissue of rats with type 1 diabetes","volume":"21","author":"Heidarisasan","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1002\/anie.200900441","article-title":"Nanogels as pharmaceutical carriers: Finite networks of infinite capabilities","volume":"48","author":"Kabanov","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Yin, Y., Hu, B., Yuan, X., Cai, L., Gao, H., and Yang, Q. (2020). Nanogel: A Versatile Nano-Delivery System for Biomedical Applications. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030290"},{"key":"ref_118","first-page":"e68633","article-title":"A Comprehensive Review of Nanogel-Based Drug Delivery Systems","volume":"16","author":"Ferozekhan","year":"2024","journal-title":"Cureus"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Delgado-Pujol, E.J., Mart\u00ednez, G., Casado-Jurado, D., V\u00e1zquez, J., Le\u00f3n-Barberena, J., Rodr\u00edguez-Lucena, D., Torres, Y., Alcudia, A., and Begines, B. (2025). Hydrogels and Nanogels: Pioneering the Future of Advanced Drug Delivery Systems. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17020215"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"9163","DOI":"10.1039\/C9NR01554J","article-title":"Glucose and H2O2 dual-sensitive nanogels for enhanced glucose-responsive insulin delivery","volume":"11","author":"Li","year":"2019","journal-title":"Nanoscale"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Torres, J., Oses, J.V., Rabasco-\u00c1lvarez, A.M., Gonz\u00e1lez-Rodr\u00edguez, M.L., and Garc\u00eda, M.C. (2025). Innovations in Cancer Therapy: Endogenous Stimuli-Responsive Liposomes as Advanced Nanocarriers. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17020245"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Liu, P., Chen, G., and Zhang, J. (2022). A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives. Molecules, 27.","DOI":"10.3390\/molecules27041372"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"49119","DOI":"10.1039\/D5RA07152F","article-title":"Nanoliposome-based drug delivery systems for the treatment of diabetes mellitus: A review","volume":"15","author":"Umar","year":"2025","journal-title":"RSC Adv."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Liu, G., He, S., Ding, Y.U., Chen, C., Cai, Q., and Zhou, W. (2021). Multivesicular Liposomes for Glucose-Responsive Insulin Delivery. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010021"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2020.09.009","article-title":"Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval","volume":"156","author":"Hwang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1021\/acs.biomac.8b01508","article-title":"Glucose-Responsive Polymeric Micelles via Boronic Acid-Diol Complexation for Insulin Delivery at Neutral pH","volume":"20","author":"Gaballa","year":"2019","journal-title":"Biomacromolecules"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Mansoor, S., Kondiah, P.P.D., Choonara, Y.E., and Pillay, V. (2019). Polymer-Based Nanoparticle Strategies for Insulin Delivery. Polymers, 11.","DOI":"10.3390\/polym11091380"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jddst.2019.01.007","article-title":"Development of bi-polymer lipid hybrid nanocarrier (BLN) to improve the entrapment and stability of insulin for efficient oral delivery","volume":"49","author":"Boushra","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijbiomac.2020.05.097","article-title":"Development of glucose oxidase-immobilized alginate nanoparticles for enhanced glucose-triggered insulin delivery in diabetic mice","volume":"159","author":"Chai","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"21927","DOI":"10.1021\/acsami.8b06998","article-title":"Self-Regulated Carboxyphenylboronic Acid-Modified Mesoporous Silica Nanoparticles with \u201cTouch Switch\u201d Releasing Property for Insulin Delivery","volume":"10","author":"Hou","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"120458","DOI":"10.1016\/j.biomaterials.2020.120458","article-title":"Microgel en-capsulated nanoparticles for glucose-responsive insulin delivery","volume":"267","author":"Volpatti","year":"2021","journal-title":"Biomaterials"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Li, Z., Jiang, J., Zhu, Z., Luo, C., Xu, C., Chen, C., Ren, G., Huang, R., and He, D. (2026). Material-driven glucose responsiveness in insulin delivery systems: Carrier selection and performance. Front Endocrinol., 17.","DOI":"10.3389\/fendo.2026.1825247"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41551-023-01138-7","article-title":"Week-long normoglycaemia in diabetic mice and minipigs via a subcutaneous dose of a glu-cose-responsive insulin complex","volume":"8","author":"Zhang","year":"2024","journal-title":"Nat. BioMed Eng."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Ghazwani, M., Hani, U., Kyada, A., Ballal, S., Issa, B.S., Abosaoda, M.K., Singh, A., Sabarivani, A., and Ray, S. (2025). Advancements in insulin delivery: The potential of natural polymers for improved diabetes management. Front Bioeng. Biotechnol., 13.","DOI":"10.3389\/fbioe.2025.1566743"},{"key":"ref_135","first-page":"41","article-title":"Cutting-edge nanotechnology in diabetes care: Metamorphosing diagnostics and treatment strategies","volume":"12","author":"Sarkhel","year":"2026","journal-title":"Future J. Pharm. Sci."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Leung, H.M.C., Forlenza, G.P., Prioleau, T.O., and Zhou, X. (2023). Noninvasive glucose sensing in vivo. Sensors, 23.","DOI":"10.3390\/s23167057"},{"key":"ref_137","first-page":"45","article-title":"Nanomedicine in the treatment of diabetes: Emerging nanotherapeutic strategies of novel drug delivery systems","volume":"10","author":"Patel","year":"2025","journal-title":"Eur. Med. J."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Roy, P.G., Zhang, J., Bhattacharya, K., Banerjee, P., Shen, J., and Zhou, S. (2025). One-pot synthesis of phenylboronic acid-based microgels for tunable gate of glucose-responsive insulin release at physiological pH. Molecules, 30.","DOI":"10.3390\/molecules30153059"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e35636","DOI":"10.1016\/j.heliyon.2024.e35636","article-title":"Therapeutic effect of oral insu-lin-chitosan nanobeads pectin-dextrin shell on streptozotocin-diabetic male albino rats","volume":"10","author":"Ramadan","year":"2024","journal-title":"Heliyon"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1186\/s12951-025-03677-4","article-title":"Engineered GLP-1R-targeting nanoplatforms: Multimodal therapeutics in human diseases","volume":"23","author":"Zeng","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"ref_141","first-page":"549","article-title":"Innovations and challenges in bioresponsive materials for effective drug delivery in diabetes mellitus","volume":"4","author":"Mageta","year":"2025","journal-title":"Acta Mater. Med."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Dinh, C.T., Nguyen, L.P., Pham, U.T., Nguyen, A.M., Do, H.T.M., Tran, T.Q., Luu, P.D., Doan, T.D., Bui, M.T.H., and Nguyen, D.T. (2025). Systematic development and characterization of en-zyme-free, borax-crosslinked microneedles for glucose-responsive insulin delivery and in vivo glycemic mitigation. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17121578"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Karim, A.M. (2025). Smart antidiabetic nanomedicine: A revolutionized therapeutic approach for treatment of diabetes mellitus. Bioengineering, 12.","DOI":"10.3390\/bioengineering12121309"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"102405","DOI":"10.1016\/j.mtbio.2025.102405","article-title":"Glucose-responsive nanozyme hydrogel for glycemic control and catalytic anti-infective therapy in diabetic wound healing","volume":"35","author":"Tai","year":"2025","journal-title":"Mater. Today Bio."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1021\/acssensors.5c00652","article-title":"Microneedle-Based multiplexed monitoring of diabetes bi-omarkers: Capabilities beyond glucose toward closed-loop theranostic systems","volume":"10","author":"Moonla","year":"2025","journal-title":"ACS Sens."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12951-022-01451-4","article-title":"Bioimaging guided pharmaceutical evaluations of nano-medicines for clinical translations","volume":"20","author":"Tuguntaev","year":"2022","journal-title":"J. Nanobiotechnol"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Mlynarska, E., Czarnik, W., Dzieza, N., Jedraszak, W., Majchrowicz, G., Prusinowski, F., Stabrawa, M., Rysz, J., and Franczyk, B. (2025). Type 2 diabetes mellitus: New patho-genetic mechanisms, treatment and the most important complications. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26031094"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.addr.2012.08.005","article-title":"Interactions of nanomaterials and biological systems: Im-plications to personalized nanomedicine","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Mayordomo, N.M., Zatarain-Beraza, A., Valerio, F., \u00c1lvarez-M\u00e9ndez, V., Turegano, P., Herranz-Garc\u00eda, L., de Aguileta, A.L., Cattani, N., \u00c1lvarez-Alonso, A., and Fanarraga, M.L. (2025). The protein corona paradox: Challenges in achieving true biomimetics in nanomedicines. Biomimetics, 10.","DOI":"10.3390\/biomimetics10050276"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12951-022-01343-7","article-title":"The interaction between nanoparticles and the immune system: Application in the treatment of inflammatory diseases","volume":"20","author":"Liu","year":"2022","journal-title":"J. Nanobiotechnol"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.2147\/IJN.S129300","article-title":"Protein corona: A new approach for nanomedicine design","volume":"12","author":"Nguyen","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.apsb.2020.08.016","article-title":"Can nanoparticles and nano-protein interactions bring a bright future for insulin delivery?","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"100266","DOI":"10.1016\/j.onano.2025.100266","article-title":"Nanodiagnostics and nanotoxicology: A systematic review and meta-analysis on nanoparticle applications and safety in metabolic organs","volume":"27","author":"Murali","year":"2026","journal-title":"OpenNano"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s42269-024-01182-6","article-title":"Silver nanoparticles in diabetes mellitus: Therapeutic potential and mechanistic insights","volume":"48","author":"Paul","year":"2024","journal-title":"Bull. Natl. Res. Cent."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"6231482","DOI":"10.1155\/2018\/6231482","article-title":"Nanoparticles in medicine: A focus on vascular oxidative stress","volume":"2018","author":"Mauricio","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"100117","DOI":"10.1016\/j.pscia.2026.100117","article-title":"Toxicity of nanostructures in drug delivery ap-plications","volume":"4","author":"Edo","year":"2026","journal-title":"Pharm. Sci. Adv."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Mathis, B.J., Zaboronok, A., Shi, Y., Nagumo, Y., Nishiyama, H., and Hiramatsu, Y. (2026). Nanoparticle clearance and new horizons in engineered drug delivery. Pharmaceutics, 18.","DOI":"10.3390\/pharmaceutics18040471"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s11671-026-04589-4","article-title":"Smart nanomaterials enabling drug delivery and glucose monitoring for diabetes management","volume":"21","author":"Gopalakrishnan","year":"2026","journal-title":"Discov. Nano"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"107120","DOI":"10.1016\/j.jddst.2025.107120","article-title":"Progress on drug nanoparticle manufacturing: Exploring the adaptability of batch bottom-up approaches to continuous manufacturing","volume":"111","author":"Costa","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1039\/D5MA00359H","article-title":"Size and surface properties of polydo-pamine nanoparticles tunable via controlled oxidation conditions","volume":"6","author":"Nucera","year":"2025","journal-title":"Mater. Adv."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"109127","DOI":"10.1016\/j.surfin.2026.109127","article-title":"Mapping polydopamine nanoparticle maturation over 1-240 hours: Linking morphology, surface accessibility, and redox response","volume":"88","author":"Benvenuto","year":"2026","journal-title":"Surf. Interfaces"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Soares, S., Sousa, J., Pais, A., and Vitorino, C. (2018). Nanomedicine: Principles, properties, and regulatory issues. Front Chem., 6.","DOI":"10.3389\/fchem.2018.00360"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e1902004","DOI":"10.1002\/adma.201902004","article-title":"Glucose-responsive insulin and delivery systems: Innovation and trans-lation","volume":"32","author":"Wang","year":"2020","journal-title":"Adv. Mater."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"100048","DOI":"10.1016\/j.onano.2022.100048","article-title":"Scale-up polymeric-based nanoparticles drug delivery systems: De-velopment and challenges","volume":"7","author":"Herdiana","year":"2022","journal-title":"OpenNano"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s44301-025-00008-2","article-title":"Nanotechnology in medicine: A double-edged sword for health outcomes","volume":"1","author":"Fortune","year":"2025","journal-title":"Health Nanotechnol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"Dordevic","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Souto, E.B., Silva, G.F., Dias-Ferreira, J., Zielinska, A., Ventura, F., Durazzo, A., Lucarini, M., Novellino, E., and Santini, A. (2020). Nanopharmaceutics: Part I-clinical trials legislation and good manufacturing practices (GMP) of nanotherapeutics in the EU. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12020146"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addr.2018.06.024","article-title":"Regulatory challenges of nanomedicines and their follow-on versions: A generic or similar approach?","volume":"131","author":"Muhlebach","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Wang, Y., and Grainger, D.W. (2022). Regulatory considerations specific to liposome drug development as complex drug products. Front Drug Deliv., 2.","DOI":"10.3389\/fddev.2022.901281"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2502315","DOI":"10.1002\/smll.202502315","article-title":"Nanoparticle therapeutics in clinical perspective: Classification, mar-keted products, and regulatory landscape","volume":"21","author":"Desai","year":"2025","journal-title":"Small"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Alshawwa, S.Z., Kassem, A.A., Farid, R.M., Mostafa, S.K., and Labib, G.S. (2022). Nanocarrier drug delivery systems: Characterization, limitations, future perspectives and implementation of artificial intelligence. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14040883"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Alarcon, R., Walter, M., Paez, M., and Azocar, M.I. (2023). Ostwald ripening and antibacterial activity of silver nanoparticles capped by an-ti-inflammatory ligands. Nanomaterials, 13.","DOI":"10.3390\/nano13030428"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Gonzalez-Garibay, A.S., Sanchez-Hernandez, I.M., Torres-Gonzalez, O.R., Hernandez-Avina, A.S., Villarreal-Amezquita, A.A., and Pa-dilla-Camberos, E. (2025). Antidiabetic activity of silver nanoparticles biosynthesized with Stenocereus queretaroensis flower extract. Pharmaceuticals, 18.","DOI":"10.3390\/ph18091310"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Souto, E.B., Souto, S.B., Campos, J.R., Severino, P., Pashirova, T.N., Zakharova, L.Y., Silva, A.M., Durazzo, A., Lucarini, M., and Izzo, A.A. (2019). Nanoparticle delivery systems in the treatment of diabetes complications. Molecules, 24.","DOI":"10.3390\/molecules24234209"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2017.01.043","article-title":"Glucose-responsive insulin release: Analysis of mechanisms, formulations, and evaluation criteria","volume":"263","author":"Yang","year":"2017","journal-title":"J. Control Release"},{"key":"ref_177","first-page":"100730","article-title":"Advances in saliva-based glucose sensors","volume":"28","author":"Sharma","year":"2026","journal-title":"Biosens. Bioelectron. X"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"120209","DOI":"10.1016\/j.biomaterials.2020.120209","article-title":"Targeted nanoparticles towards increased L cell stimulation as a strategy to improve oral peptide delivery in incretin-based diabetes treatment","volume":"255","author":"Xu","year":"2020","journal-title":"Biomaterials"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2022.02.017","article-title":"Microfluidic technologies and devices for lipid nanoparticle-based RNA de-livery","volume":"344","author":"Maeki","year":"2022","journal-title":"J. Control Release"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1038\/s41467-025-62994-2","article-title":"A chemical autonomous robotic platform for end-to-end synthesis of nano-particles","volume":"16","author":"Gao","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Journal of Functional Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-4983\/17\/9\/424\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:33:56Z","timestamp":1787567636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-4983\/17\/9\/424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":180,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jfb17090424"],"URL":"https:\/\/doi.org\/10.3390\/jfb17090424","relation":{},"ISSN":["2079-4983"],"issn-type":[{"value":"2079-4983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]}}}